3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent studies have shown that lymphoid enhancer binding factor 1 (LEF1) is a useful marker for chronic lymphocytic B-cell leukemia (CLL)/small lymphocytic lymphoma. Yet, it is not still being widely used in a diagnostic setting. In this study, we document the experience with LEF1 immunohistochemistry during routine diagnostics.

          Related collections

          Author and article information

          Journal
          Am J Clin Pathol
          American journal of clinical pathology
          Oxford University Press (OUP)
          1943-7722
          0002-9173
          Mar 01 2017
          : 147
          : 3
          Affiliations
          [1 ] From the Department of Cellular and Molecular Pathology, Hammersmith Hospital Campus, Imperial College Healthcare NHS Trust, London, UK; and.
          [2 ] Institute of Pathology, University Hospital Basel, Basel, Switzerland.
          Article
          3063263
          10.1093/ajcp/aqw208
          28395058
          840478d1-6f7d-4d5b-a0f7-9fdf153a8b12
          History

          Immunohistochemistry,LEF1,CLL,Routine diagnostics
          Immunohistochemistry, LEF1, CLL, Routine diagnostics

          Comments

          Comment on this article